𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bisphosphonate resistance in Paget's disease of bone

✍ Scribed by Fred Joshua; Martin Epstein; Gabor Major

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
49 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Heterogeneity in Paget disease of the bo
Heterogeneity in Paget disease of the bone
✍ Nance, Martha A. ;Nuttall, Frank Q. ;Econs, Michael J. ;Lyles, Kenneth W. ;Viles πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 2 views

Paget disease of the bone is a common skeletal disorder. Recently, a gene for Paget disease was localized to 18q with subsequent evidence for linkage heterogeneity. We report the identification and clinical characterization of a large pedigree of Paget disease and demonstrate that the Paget disease

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
✍ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 382 KB

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients

Paget's disease of the nipple
Paget's disease of the nipple
✍ Mr. A. R. Dixon; M. H. Galea; I. O. Ellis; C. W. Elston; R. W. Blamey πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 262 KB